Penn Mutual Asset Management

Holdings History for Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Symbol: PHAT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.62%	0%	$1,041,885	62,802	0		$16.59	Q4 2025
30 Sep 2025	1.4%	0%	$739,180	62,802	0		$11.77	Q3 2025
30 Jun 2025	1.1%	0%	$602,271	62,802	0		$9.59	Q2 2025
31 Mar 2025	0.76%	0%	$393,769	62,802	0		$6.27	Q1 2025
31 Dec 2024	0.92%	0%	$509,952	62,802	0		$8.12	Q4 2024
30 Sep 2024	2.3%	0%	$1,135,460	62,802	0		$18.08	Q3 2024
30 Jun 2024	1.4%	0%	$646,861	62,802	0		$10.30	Q2 2024
31 Mar 2024	1.4%	0%	$666,957	62,802	0		$10.62	Q1 2024
31 Dec 2023	0.44%	0%	$573,382	62,802	0		$9.13	Q4 2023
30 Sep 2023	0.61%	0%	$651,257	62,802	0		$10.37	Q3 2023
30 Jun 2023	0.81%	0%	$899,325	62,802	0		$14.32	Q2 2023
31 Mar 2023	0.43%	0%	$448,406	62,802	0		$7.14	Q1 2023
31 Dec 2022	0.79%	-0.3%	$704,638	62,802	-24,138	-28%	$11.22	Q4 2022
30 Sep 2022	1.3%	0%	$963,000	86,940	0		$11.08	Q3 2022
30 Jun 2022	0.99%	0%	$734,000	86,940	0		$8.44	Q2 2022
31 Mar 2022	1.4%	+1.4%	$1,183,000	86,940	+86,940	NEW	$13.61	Q1 2022
31 Dec 2021		-4.7%	$0	0	-86,940	-100%	$12.23	Q4 2021
30 Sep 2021	4.7%	0%	$2,791,000	86,940	0		$32.10	Q3 2021
30 Jun 2021	4.3%	0%	$2,943,000	86,940	0		$33.85	Q2 2021
31 Mar 2021	3.7%	0%	$3,265,000	86,940	0		$37.55	Q1 2021
31 Dec 2020	2.6%	0%	$2,888,000	86,940	0		$33.22	Q4 2020
30 Sep 2020	4.5%	0%	$3,188,000	86,940	0		$36.67	Q3 2020
30 Jun 2020	4.2%	+4.2%	$2,861,000	86,940	+86,940	NEW	$32.91	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.